p53 Overview
p53 Invest is a Norwegian investment firm established in 2018, specializing in identifying and investing in innovative healthcare companies, particularly in biotechnology and medical devices. The firm aims to support groundbreaking ideas that transform people's lives and enhance accessibility to cutting-edge treatments and healthcare solutions.
Is p53 the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with p53, along with a list of other relevant VCs, is available on Hopohopo.io.
p53
Investment focus
Invest in
- Nordics 2 / 9
- Western Europe 4 / 14
- North America 1 / 5
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Series A
First ticket size
€1,000,000 - €10,000,000
Contact information
Investment Director
Lars Knudsen
How to approach funds like p53
When approaching p53 Invest, founders should highlight the scientific rigor and clinical validation behind their technology, as well as a clear path to regulatory approval and market adoption. Demonstrating a strong understanding of the healthcare ecosystem, including reimbursement strategies and partnerships with key stakeholders, will resonate. Articulate how your solution addresses unmet medical needs and show traction through early data or pilot programs to stand out.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
